Skip to main content

Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)

Core Curriculum

J Am Coll Cardiol, 76 (11) 1375–1384
Sections

Abstract

The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with this novel coronavirus. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating an ST-elevation myocardial infarction (STEMI) presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury, and the prevalence of COVID-19 disease in the U.S. population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option.

  • 1. Huang C., Wang Y., Li X., et al. "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet 2020;395:497-506.

    CrossrefMedlineGoogle Scholar
  • 2. Ruan Q., Yang K., Wang W., Jiang L., Song J. "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China". Intensive Care Med 2020;46:846-848.

    CrossrefMedlineGoogle Scholar
  • 3. Wang D., Hu B., Hu C., et al. "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China". JAMA 2020;323:1061-1069.

    CrossrefMedlineGoogle Scholar
  • 4. Shi S., Qin M., Shen B., et al. "Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China". JAMA Cardiol 2020Mar25. [E-pub ahead of print].

    CrossrefGoogle Scholar
  • 5. Guo T., Fan Y., Chen M., et al. "Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)". JAMA Cardiol 2020Mar27[E-pub ahead of print].

    CrossrefGoogle Scholar
  • 6. Tam C.F., Cheung K.S., Lam S., et al. "Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China". Circ Cardiovasc Qual Outcomes 2020;13:e006631.

    CrossrefMedlineGoogle Scholar
  • 7. O'Gara P.T., Kushner F.G., Ascheim D.D., et al. "2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". J Am Coll Cardiol 2013;61:e78-e140.

    View ArticleGoogle Scholar
  • 8. Henry T.D. "From concept to reality: a decade of progress in regional ST-elevation myocardial infarction systems". Circulation 2012;126:166-168.

    CrossrefMedlineGoogle Scholar
  • 9. Inui S., Fujikawa A., Jitsu M., et al. "Chest CT findings in cases from the cruise ship “diamond princess” with coronavirus disease 2019 (COVID-19)". Radiol Cardiothorac Imaging 2020Mar17[E-pub ahead of print].

    Google Scholar
  • 10. Bai Y., Yao L., Wei T., et al. "Presumed asymptomatic carrier transmission of COVID-19". JAMA 2020;323:1406-1407.

    CrossrefMedlineGoogle Scholar
  • 11. Garcia S., Albaghdadi M.S., Meraj P.M., et al. "Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic". J Am Coll Cardiol 2020;75:2871-2872.

    View ArticleGoogle Scholar
  • 12. FDA approval of rapid COVID-19 testing. Accessed google search April 8, 2020.

    Google Scholar
  • 13. Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. "Potential effects of coronaviruses on the cardiovascular system". JAMA Cardiol 2020Mar27. [E-pub ahead of print].

    CrossrefMedlineGoogle Scholar
  • 14. Fried J.A., Ramasubbu K., Bhatt R., et al. "The variety of cardiovascular manifestations of COVID-19". Circulation 2020;141:1930-1936.

    CrossrefMedlineGoogle Scholar
  • 15. Dauerman H.L., Sobel B.E. "Synergistic treatment of ST-segment elevation myocardial infarction with pharmacoinvasive recanalization". J Am Coll Cardiol 2003;42:646-651.

    View ArticleGoogle Scholar
  • 16. Larson D.M., Duval S., Sharkey S.W., et al. "Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers". Eur Heart J 2012;33:1232-1240.

    CrossrefMedlineGoogle Scholar
  • 17. Zeng J., Huang J., Pan L. "How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan provincial People's hospital". Intensive Care Med 2020. 1-3.

    Google Scholar
  • 18. Rab T., Kern K.B., Tamis-Holland J.E., et al. "Cardiac arrest: a treatment algorithm for emergent cardiac procedures in the resuscitated comatose patient". J Am Coll Cardiol 2015;66:62-73.

    View ArticleGoogle Scholar
  • 19. Lemkes J.S., Janssens G.N., van der Hoeven N.W., et al. "Coronary angiography after cardiac arrest without ST-segment elevation". N Engl J Med 2019;380:1397-1407.

    CrossrefMedlineGoogle Scholar
  • 20. Mehta S.R., Granger C.B., Boden W.E., et al. "Early versus delayed invasive intervention in acute coronary syndromes". N Engl J Med 2009;360:2165-2175.

    CrossrefMedlineGoogle Scholar
  • 21. "Coronavirus disease 2019 (COVID-19) Situation Report-66". Available at: https://www.who.int/docs/default-source/coronaviruse/situationreports/20200326-sitrep-66-covid-19.pdf?sfvrsn=81b94e61_2.

    Google Scholar
  • 22. "WHO Infection Prevention and Control Guidance for COVID-19". Available at: https://www.who.int/emergencies/diseases/novel-coronavirus2019/technical-guidance/infection-prevention-and-control.

    Google Scholar
  • 23. Tran K., Cimon K., Severn M., Pessoa-Silva C.L., Conly J. "Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review". PLoS ONE 2012;7:e35797.

    CrossrefGoogle Scholar
  • 24. Welt F.G.P., Shah P.B., Aronow H.D., et al. "Catheterizatiion laboratory considerations during the coronavirus (COVID-19) pandemic. From the ACC's interventional council and SCAI". J Am Coll Cardiol 2020;75:2372-2375.

    View ArticleGoogle Scholar
  • 25. Kwong J.C., Schwartz K.L., Campitelli M.A., et al. "Acute myocardial infarction after laboratory-confirmed influenza infection". N Engl J Med 2018;378:345-353.

    CrossrefMedlineGoogle Scholar
  • 26. Jollis J.G., Al-Khalidi H.R., Roettig M.L., et al. "Regional systems of care demonstration project: American Heart Association Mission: lifeline STEMI systems accelerator". Circulation 2016;134:365-374.

    CrossrefMedlineGoogle Scholar
  • 27. Ebinger J.E., Strauss C.E., Garberich R.R., et al. "Value-based ST-segmentelevation myocardial infarction care using risk-guided triage and early discharge". Circ Cardiovasc Qual Outcomes 2018;11:e004553.

    CrossrefMedlineGoogle Scholar